Health research and innovation – Coronavirus: Commission offers financing to innovative vaccines company CureVac

Today, the Commission offered up to €80 million of financial support to CureVac, a higly innovative vaccine developer from Tübingen, Germany, to scale up development and production of a vaccine against the Coronavirus in Europe.

Powered by WPeMatico